Assessing the Impact of a Mode of Vitamin D Supplementation (Sequential Dose vs Daily Dose) on the Incidence of Hypercalciuria in Subjets Aged From 2 to 18 Years
NCT ID: NCT02975492
Last Updated: 2023-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
280 participants
INTERVENTIONAL
2017-12-14
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.
NCT02238418
Effect of Vitamin D Replacement in Patients With Urolithiasis
NCT01349764
Vitamin D Supplementation in Postmenopausal Women With Osteoporosis: Proposal of a Therapeutic Regimen in Practice
NCT02518763
Cholecalciferol Supplementation Effect on Parathyroid Hormone in Hemodialysis Patients
NCT03648528
Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta
NCT01713231
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cholecalciferol sequential dose
cholecalciferol : 100 000 Unit International (UI), sequential dose (2 mL)
Cholecalciferol sequential dose
sequential dose administration of the treatment
Cholecalciferol daily dose
cholecalciferol : 1000 UI, daily dose during 28 days (0.1 ml by day)
Cholecalciferol daily dose
daily dose administration of the treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cholecalciferol sequential dose
sequential dose administration of the treatment
Cholecalciferol daily dose
daily dose administration of the treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Obtaining informed consent of the parents signed
* Participants aged 18 years included
2 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric department
Montpellier, , France
Pediatric department
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Denis MORIN, MD
Role: primary
Tu-Anh TRAN, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UF 9676
Identifier Type: OTHER
Identifier Source: secondary_id
RECHMPL15_0500
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.